228 related articles for article (PubMed ID: 17921331)
1. Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.
Hong TT; Huang J; Barrett TD; Lucchesi BR
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H145-55. PubMed ID: 17921331
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
Hennan JK; Huang J; Barrett TD; Driscoll EM; Willens DE; Park AM; Crofford LJ; Lucchesi BR
Circulation; 2001 Aug; 104(7):820-5. PubMed ID: 11502709
[TBL] [Abstract][Full Text] [Related]
3. Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine.
Gross GJ; Moore J
Pharmacology; 2004 Jul; 71(3):135-42. PubMed ID: 15161995
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on ischemic myocardium.
Robich MP; Chu LM; Feng J; Burgess TA; Laham RJ; Bianchi C; Sellke FW
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1143-52. PubMed ID: 20804993
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 blockade does not impair endothelial vasodilator function in healthy volunteers: randomized evaluation of rofecoxib versus naproxen on endothelium-dependent vasodilatation.
Verma S; Raj SR; Shewchuk L; Mather KJ; Anderson TJ
Circulation; 2001 Dec; 104(24):2879-82. PubMed ID: 11739299
[TBL] [Abstract][Full Text] [Related]
6. Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells.
Di Francesco L; Totani L; Dovizio M; Piccoli A; Di Francesco A; Salvatore T; Pandolfi A; Evangelista V; Dercho RA; Seta F; Patrignani P
Circ Res; 2009 Feb; 104(4):506-13. PubMed ID: 19122175
[TBL] [Abstract][Full Text] [Related]
7. Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform.
Beverelli F; Béa ML; Puybasset L; Giudicelli JF; Berdeaux A
Fundam Clin Pharmacol; 1997; 11(3):252-9. PubMed ID: 9243257
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cyclooxygenase 2-mediated vasorelaxation in coronary arteries from insulin-resistant obese Zucker rats.
Sánchez A; Contreras C; Martínez P; Villalba N; Benedito S; García-Sacristán A; Salaíces M; Hernández M; Prieto D
Atherosclerosis; 2010 Dec; 213(2):392-9. PubMed ID: 20956003
[TBL] [Abstract][Full Text] [Related]
9. Ovariectomy increases the formation of prostanoids and modulates their role in acetylcholine-induced relaxation and nitric oxide release in the rat aorta.
Martorell A; Sagredo A; Aras-López R; Balfagón G; Ferrer M
Cardiovasc Res; 2009 Nov; 84(2):300-8. PubMed ID: 19567483
[TBL] [Abstract][Full Text] [Related]
10. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway.
Blanco-Rivero J; Márquez-Rodas I; Xavier FE; Aras-López R; Arroyo-Villa I; Ferrer M; Balfagón G
Cardiovasc Res; 2007 Jul; 75(2):398-407. PubMed ID: 17412316
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and COX-2 inhibitor nimesulide potentiate adrenergic contractions of human gastroepiploic artery.
Aldasoro M; Mauricio MD; Serna E; Cortina B; Medina P; Segarra G; Novella S; Vila JM
Am J Hypertens; 2007 May; 20(5):514-9. PubMed ID: 17485013
[TBL] [Abstract][Full Text] [Related]
12. Human pharmacology of naproxen sodium.
Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
[TBL] [Abstract][Full Text] [Related]
13. Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs.
Steiner AA; Li S; Llanos-Q J; Blatteis CM
Neuroimmunomodulation; 2001; 9(5):263-75. PubMed ID: 11964521
[TBL] [Abstract][Full Text] [Related]
14. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
Trimarco B; Cuocolo A; Ricciardelli B; Patrignani P; Volpe M; de Luca N; Condorelli M
J Pharmacol Exp Ther; 1986 May; 237(2):589-99. PubMed ID: 3084760
[TBL] [Abstract][Full Text] [Related]
15. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Weir MR; Sperling RS; Reicin A; Gertz BJ
Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
[TBL] [Abstract][Full Text] [Related]
16. Role of prostaglandins in urotensin II-induced vasodilatation in the coronary arteries of aged rats.
Ishihata A; Ogaki T; Aita T; Katano Y
Eur J Pharmacol; 2005 Oct; 523(1-3):119-26. PubMed ID: 16226251
[TBL] [Abstract][Full Text] [Related]
17. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
Schumacher WA; Lucchesi BR
J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
[TBL] [Abstract][Full Text] [Related]
18. Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events.
Mukherjee D
Biochem Pharmacol; 2002 Mar; 63(5):817-21. PubMed ID: 11911832
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-dependent mechanisms mediate in part the anti-dilatory effects of perivascular adipose tissue in uterine arteries from pregnant rats.
Osikoya O; Cushen SC; Ricci CA; Goulopoulou S
Pharmacol Res; 2021 Sep; 171():105788. PubMed ID: 34311071
[TBL] [Abstract][Full Text] [Related]
20. Resistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation.
Dick GM; Katz PS; Farias M; Morris M; James J; Knudson JD; Tune JD
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2997-3002. PubMed ID: 16905596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
